| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3186718 | Annales de Dermatologie et de Vénéréologie | 2013 | 4 Pages |
Abstract
Our case confirms the previously reported dramatic efficacy of anti-TNF biological agents in recalcitrant SWD but highlights the possibility of subsequent loss of response. Furthermore, it illustrates the efficacy of adalimumab in this indication.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M. Versini, F. Mantoux, K. Angeli, T. Passeron, J.-P. Lacour,